An Open-label Phase 4 Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials